PsychopharmINFO Newsletter Sign-up

PsychopharmINFO Newsletter

• 10% of all proceeds goes to NAMI.
• Check out first three issues of Newsletter above! Or, click on the money pill to order now.

If you have spent any time at all on our site, you are already aware of the free benefits you get from PsychopharmINFO.com.
(If not, click here to check it out now.)
These include:

the easy way for you to stay current on hot-off-the-press antidepressant research every month

the fast way to scan over 4000 news sources monthly for the medications you are interested in following

month-by-month lists make it simple for you to navigate news and articles of interest

"Highlights" of each month's PubMed research articles take you directly to the PubMed abstracts

monthly articles are also categorized into Side Effects, Drug Interactions, and Clinical Trials, to save you time and aggravation

did I already say it was FREE?

Here are some facts you may not yet know:

in December we had 12,048 page views in 7276 different visits by 5391 different sites

our traffic is growing by 30% per month

most of our visitors are either (1) folks who take a personal interest in these medications and want to know everything they can about their body and what they put into it, or (2) mental health professionals who enjoy this easy way to stay on top of the latest news and research

the site is maintained by an experienced, board-certified psychiatrist (yours truly), also certified in clinical psychopharmacology

it currently takes 4-6 hours per week to keep the site up to date

I'd like to add other medications to the ones we now follow, such as Zyprexa, Buspar, Lamictal, Provigil, and Neurontin

This has been a labor of love for me for the past five years, as I am passionate about helping people understand mental illness and its treatment. Those of you who have followed me here from my three years as a weekly host on AOL's Depression Information Forum know of my personal investment in sharing this knowledge.

I-pill bullet
So here's the problem I'm now facing. To continue to do this -- and do it well -- I need to generate some income to at least cover my production costs and my time. While I'm at it, I'd like to help NAMI.

I've thought about selling ads to the pharmaceutical companies (they'd love that), but I don't like the perception that they could taint our otherwise unbiased information.

So I'd rather come to you and ask for money.

I don't want to make the site subscription-only ... after all, my goal is to help inform as many people as possible.
So here's what I am doing. I've started up a WEEKLY NEWSLETTER. One that provides you with:

WEEKLY updates about psychopharm articles help you keep tabs on your health.

WEEKLY updates about side effects, with particular attention to the most troublesome ones: weight gain and sexual side effects.

WEEKLY updates about drug interactions and clinical trials.

WEEKLY news headlines in your mailbox keep you "in the know".

WEEKLY updates about new medications so you are up-to-date.

PLAIN LANGUAGE commentary on select articles and new discoveries.

LINKS to sites of interest.

TABLES of information about medication use, side effects, and medication properties.

And, most importantly, KNOWLEDGE that you are helping to keep this information source alive and growing.

Okay, so here's the deal: 48 issues per year sent to your email box every Monday for US$60 per year, or US$35 for 6 months (24 issues). That's only a cup of coffee a week!

I hope you'll consider supporting this endeavor. If not, the current information will continue to be free and updated monthly, but you'll miss out on a lot of the good stuff -- and the ability to help shape the site to fit your needs.

Best wishes,
Steven R. Daviss, M.D.

P.S.: Oh, and one more thing. 10% of all gross proceeds goes to NAMI, the National Alliance for the Mentally Ill.

CLICK HERE TO ORDER NEWSLETTER
by Visa or MasterCard on our secure server.
If you'd prefer to mail your order, click here. No thanks. But add me to your mailing list so I can receive info about changes to the site, announcements, and free sample newsletters. (I don't sell or share my address list with anyone.)